Drug Topics

JULY 10, 2025

By tailoring your pharmacy to meet the needs of customers across both prescription and over-the-counter (OTC) products, you can transform your store into a long-term community destination for total health and wellness. Private-label brands allow you to deliver the same quality as larger name brands, often at a lower cost.

Health and Personal Care Stores 247

Health and Personal Care Stores Independent Pharmacies Labelling Specialty Pharmacies 247

Drug Topics

JULY 18, 2025

Simple techniques, such as color-coding or clearly labeling insulin pens and vials with a marker can help patients remember which insulin to use and when. Mealtime insulin must be taken close to eating, ranging from 30 minutes before to just after the meal, depending on the product.

Specialty Pharmacies 247

Specialty Pharmacies Compounding Independent Pharmacies Patient Care 247

Drug Topics

JUNE 12, 2025

Image Credit: sonyakamoz - stock.adobe.com "We have been conditioned to equate weight loss with health, and weight loss-resistant individuals are often labeled as failures,” Anat Yaskolka Meir, PhD, postdoctoral research fellow in the department of epidemiology at Harvard Chan School, said in a news release.

Compounding 281

Compounding Specialty Pharmacies Independent Pharmacies Immunization 281

Pharmacy Times

JULY 14, 2025

McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy.

Independent Pharmacies 129

Independent Pharmacies Compounding Pharmacies Patient Care Hospitals 129

Drug Topics

JULY 7, 2025

2 One of the risks of SGLT2is has been an increase in hematocrit levels, ranging from 2.3% in clinical trials, according to a case series published in Endocrine Abstracts.

Compounding 190

Compounding Patient Care Specialty Pharmacies FDA 190

Drug Topics

JUNE 25, 2025

of YA with obesity were prescribed OMs—predominantly GLP-1s approved for adults but used off label for younger people. Despite the high prevalence of obesity among children and YA, OM utilization remains low,” wrote authors of the abstract. 1 In the final year of the analysis (2024), just 1.5% of adolescents and 5.7%

Compounding 315

Compounding Insurance Coverage Insurance Specialty Pharmacies 315

Pharmacy Times

JULY 9, 2025

The FDA has approved an updated label with a new recommended titration dosing schedule for donanemab-azbt (Kisunla; Eli Lilly and Company) for once-monthly amyloid-targeting therapy for adults that experience early symptomatic Alzheimer disease (AD). million individuals in the United States aged 65 and older.

Labelling 65

Labelling FDA Compounding Pharmacies Independent Pharmacies 65